| The ‘risk environment’: a framework for understanding and reducing drug-related harm T Rhodes International journal of drug policy 13 (2), 85-94, 2002 | 1312 | 2002 |
| The social structural production of HIV risk among injecting drug users T Rhodes, M Singer, P Bourgois, SR Friedman, SA Strathdee Social science & medicine 61 (5), 1026-1044, 2005 | 1119 | 2005 |
| Risk environments and drug harms: a social science for harm reduction approach T Rhodes International journal of drug policy 20 (3), 193-201, 2009 | 1031 | 2009 |
| HIV and risk environment for injecting drug users: the past, present, and future SA Strathdee, TB Hallett, N Bobrova, T Rhodes, R Booth, R Abdool, ... The Lancet 376 (9737), 268-284, 2010 | 641 | 2010 |
| Global overview of injecting drug use and HIV infection among injecting drug users C Aceijas, GV Stimson, M Hickman, T Rhodes Aids 18 (17), 2295-2303, 2004 | 563 | 2004 |
| Prevention of HIV infection for people who inject drugs: why individual, structural, and combination approaches are needed L Degenhardt, B Mathers, P Vickerman, T Rhodes, C Latkin, M Hickman The Lancet 376 (9737), 285-301, 2010 | 542 | 2010 |
| Global estimates of prevalence of HCV infection among injecting drug users C Aceijas, T Rhodes International journal of drug policy 18 (5), 352-358, 2007 | 482 | 2007 |
| Risk theory in epidemic times: sex, drugs and the social organisation of ‘risk behaviour’ T Rhodes Sociology of Health & Illness 19 (2), 208-227, 1997 | 423 | 1997 |
| Interventions to prevent HIV and hepatitis C in people who inject drugs: a review of reviews to assess evidence of effectiveness GJ MacArthur, E van Velzen, N Palmateer, J Kimber, A Pharris, V Hope, ... International Journal of Drug Policy 25 (1), 34-52, 2014 | 379 | 2014 |
| The EASL–Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortality TH Karlsen, N Sheron, S Zelber-Sagi, P Carrieri, G Dusheiko, E Bugianesi, ... The Lancet 399 (10319), 61-116, 2022 | 324 | 2022 |
| Evidence for the effectiveness of sterile injecting equipment provision in preventing hepatitis C and human immunodeficiency virus transmission among injecting drug users: a … N Palmateer, J Kimber, M Hickman, S Hutchinson, T Rhodes, D Goldberg Addiction 105 (5), 844-859, 2010 | 320 | 2010 |
| Transition and the HIV risk environment T Rhodes, M Simic Bmj 331 (7510), 220-223, 2005 | 316 | 2005 |
| Hepatitis C treatment access and uptake for people who inject drugs: a review mapping the role of social factors M Harris, T Rhodes Harm reduction journal 10, 1-11, 2013 | 310 | 2013 |
| Structural violence and structural vulnerability within the risk environment: theoretical and methodological perspectives for a social epidemiology of HIV risk among injection … T Rhodes, K Wagner, SA Strathdee, K Shannon, P Davidson, P Bourgois Rethinking social epidemiology: Towards a science of change, 205-230, 2012 | 294 | 2012 |
| HIV infection associated with drug injecting in the newly independent states, eastern Europe: the social and economic context of epidemics T Rhodes, A Ball, GV Stimson, Kobyshcha, C Fitch, V Pokrovsky, Marina, ... Addiction 94 (9), 1323-1336, 1999 | 291 | 1999 |
| Public injecting and the need for ‘safer environment interventions’ in the reduction of drug‐related harm T Rhodes, J Kimber, W Small, J Fitzgerald, T Kerr, M Hickman, ... Addiction 101 (10), 1384-1393, 2006 | 282 | 2006 |
| Situational factors influencing drug injecting, risk reduction and syringe exchange in Togliatti City, Russian Federation: a qualitative study of micro risk environment T Rhodes, L Mikhailova, A Sarang, CM Lowndes, A Rylkov, M Khutorskoy, ... Social science & medicine 57 (1), 39-54, 2003 | 282 | 2003 |
| Public injection settings in Vancouver: physical environment, social context and risk W Small, T Rhodes, E Wood, T Kerr International Journal of Drug Policy 18 (1), 27-36, 2007 | 253 | 2007 |
| Police violence and sexual risk among female and transvestite sex workers in Serbia: qualitative study T Rhodes, M Simić, S Baroš, L Platt, B Žikić Bmj 337, 2008 | 246 | 2008 |
| Impact of opioid substitution therapy on antiretroviral therapy outcomes: a systematic review and meta-analysis AJ Low, G Mburu, NJ Welton, MT May, CF Davies, C French, KM Turner, ... Clinical Infectious Diseases 63 (8), 1094-1104, 2016 | 240 | 2016 |
